Introduction {#sec1-1}
============

Necrotizing fasciitis, also known as flesh-eating disease, is a rare infection of the deeper layers of skin and subcutaneous tissues, and easily spreads across the fascial plane within those tissues. As bacterial toxins and the immune response cause vasoconstriction of the vasculature, the fascial spaces become avascular resulting in necrosis, which also prevents penetration of antibiotics into the tissues.[@ref1] Common causes are Group A streptococcus (GAS) (*Streptococcus pyogenes*), *Staphylococcus aureus*, *Vibrio vulnificus*, *Clostridium perfringens*, and *Bacteroides fragilis.* Mortality ranges from 4.2 to 38% with improving prognosis as time to treatment decreases.[@ref2]

*Serratia marcescens*, a motile bacillus, gramnegative, facultative anaerobe, is an opportunistic pathogen of increasing importance. It is part of normal colon flora, and is also found in soil, sewage, and water. This Enterobacteriaceae organism also typically colonizes the respiratory and urinary tracts and causes infections in those organ systems.[@ref3] *S. marcescens* is often an opportunistic infection and may cause osteomyelitis, septic arthritis, endocarditis, and, rarely cellulitis or necrotizing fasciitis.^[@ref4]^ Soft tissue infections due to gram-negative organisms are relatively uncommon, and typical predisposing factors include: a history of trauma, alcoholism, peripheral vascular disease, systemic lupus erythematosus, immunosuppression, diabetes mellitus, urinary tract infection (UTI), bacteremia, pneumonia, infective arthritis, burns, and renal failure.^[@ref4],[@ref7]^ Other predisposing factors include: antibiotic use (most often first generation cephalosporins), steroid use, surgical instrumentation, urinary catheters, respiratory equipment, intravenous lines, injections, lacerations, abscesses, or ulcers.[@ref8]

Common presentations of necrotizing fasciitis within 48 hours of infection include skin erythema and swelling at the affected site (97.6%), pyrexia (61.9%), hypotension (33.3%), altered consciousness (28.6%), bullous lesions (26.2%), and crepitus (9.5%). Hypotension, altered consciousness, ventilator support, ALT \> two-fold of normal, serum creatinine \>177 µmol/L, thrombocytopenia (\<100×10^9^/L), and worsening symptoms within 48 hours of admission have been associated with higher fatality rates.[@ref9] Lack of response to narrow-spectrum antibiotics, bullae formation, or a rapidly worsening clinical course, should heighten the suspicion for uncommon organisms like *S. marcescens*.

Reports of *S. marcescens* necrotizing fasciitis cases have increased in the literature. In this study, we identify characteristics, trends, and risk factors of those infections to better prepare the medical community and prevent poor outcomes.

Materials and Methods {#sec1-2}
=====================

PubMed was used to search for cases of necrotizing fasciitis caused by *Serratia marcescens* published in the English language literature between 1966 and 2013. Keywords that were used included: *Serratia marcescens*, necrotizing, and fasciitis. We identified eleven additional cases of necrotizing fasciitis due to *S. marcescens* in the literature since the latest review in 2001, which are included in [Table 1](#table001){ref-type="table"}.^[@ref4],[@ref7],[@ref10]^ Cases were categorized as being healthcare-associated infections or community-acquired infections based on the Centers for Disease Control and Prevention (CDC) definition of healthcare-associated infections (HAIs) as infections that patients acquire during the course of receiving healthcare treatment for other conditions.[@ref23]

Case Report {#sec1-3}
===========

We recently identified a case involving a 51-year-old African-American woman who presented 3 weeks postoperatively after undergoing a bifemoral bypass and left distal femoral aneurysm repair for symptomatic peripheral vascular disease. She had a long standing history of smoking and hypertension. On presentation, the patient reported having fever, chills, nausea, vomiting, and diarrhea for 6 days, redness and odorous discharge from her surgical incision site for one day. Additional history revealed that she was cleaning her wound with well water. On examination, there was erythema extending from the periumbilical area to her left groin, along with severe tenderness to palpation in that area. No crepitus was felt on palpation. Her temperature on admission was 36.9°C, blood pressure was 162/109 mmHg, respirations were 24 breaths per minute, and she was in no acute distress. Her white blood cell count was 9.8×10^9^/L, C reactive protein (CRP) was 16.57 nmol/L, serum creatine kinase level was 57 U/L, serum electrolytes, renal, liver functions and immunoglobulin levels were normal and blood and urine cultures were negative. The patient was started on intravenous vancomycin and meropenem and underwent multiple debridements of the abdominal wound and left groin region. Intraoperative findings confirmed the presence of deep necrotic fascia and non-adherent subcutaneous tissue. Histopathology of debrided tissue indicated acute and chronic inflammation with infiltration of granulocytes and necrosis involving the fibroadipose tissue and skeletal muscle. Intraoperative wound cultures were positive for *Serratia marcescens*. Based on sensitivities, antibiotics were changed to intravenous levofloxacin MIC \<2 mcg/mL. She also received negative-pressure wound therapy using vacuum assisted closure. The patient improved clinically and was successfully discharged on oral levofloxacin to complete a total of 3 weeks of treatment.

Results {#sec1-4}
=======

Since 1966, there have been 17 documented cases of necrotizing fasciitis caused by *S. marcescens* ([Table 1](#table001){ref-type="table"}).^[@ref4],[@ref7],[@ref10]^ Eight (47%) of those cases occurred within the past five years.^[@ref4],[@ref7],[@ref15]^ Among all of the identified cases, 10 (59%) impacted a leg, and 1 (5.9%) affected the forearm, the cervical spine, the axilla and chest wall, a venous access site, the oropharynx, the chest wall, or the lower abdomen. Thirteen (77%) of the cases had blood cultures that were positive for *S. marcescens*. Ten cases (59%) were community-acquired infections, and 7 cases (41%) were healthcare-associated infections. An overwhelming number of cases (81.3%) had pre-existing open wounds. Seven cases (41%) were immunocompromized, 5 cases (29%) had kidney disease, and 4 cases (24%) had diabetes. A majority (59%) of the cases were among females. Three of the cases (18%) were children.

Nine out of seventeen cases (53%) died as a result of necrotizing fasciitis and its complications. Six of the cases (67%) that died had community-acquired infections. Individuals with positive versus negative blood cultures were more likely to die (88% *vs*. 75%). Patients who did not receive surgical debridement had inferior outcomes; they had a mortality of 71% compared to 40% among those who received surgical intervention as opposed to debridement. Additionally, all patients (18%, n=3) who received only antibiotics and the one patient who received only surgical debridement died. All previously healthy patients (18%, n=3) also died. A majority of those that recovered had a surgical procedure in the hospital prior to symptom onset such as below the knee amputation or venous access port implantation (75%, n=8).

Discussion and Conclusions {#sec1-5}
==========================

Necrotizing fasciitis is a deep infection of the subcutaneous tissue that results in progressive destruction of fascia and fat. The disease is classified as type I (polymicrobial infection), type II (monomicrobial) and type III gas gangrene, or clostridial myonecrosis. Type I infection involves anaerobic species in combination with one or more facultative anaerobic streptococci (other than group A) and members of the Enterobacteriaceae family. Type II infection is commonly caused by group A streptococci or other beta-hemolytic streptococci that are isolated alone or in combination with other species, most frequently *S. aureus*. These infections are also commonly referred as flesh eating infection. Among those with necrotizing fasciitis, the affected area is typically erythematous, swollen, warm, and exquisitely tender. The infection progresses rapidly over several days, with changes in skin color from red-purple to patches of blue-gray. Skin breakdown with bullae (containing thick pink or purple fluid) and frank cutaneous gangrene may be observed within three to five days.[@ref16] The development of anesthesia may precede the appearance of skin necrosis and provide a clue that the process is necrotizing fasciitis rather than cellulitis. In advanced infection, high fever and systemic toxicity are generally observed.

Individuals with positive blood cultures typically have poorer prognosis and higher mortality rates.^[@ref1],[@ref25]^ Treatment of necrotizing infection consists of early and aggressive surgical exploration and debridement of necrotic tissue, together with broad spectrum empiric antibiotic therapy and hemodynamic support as necessary.^[@ref4],[@ref26]^ Acceptable antibiotic regimens prior to identification of the causative organism(s) include administration of a carbapenem or beta-lactam/beta-lactamase inhibitor, together with clindamycin (600 to 900 milligrams intravenously every eight hours), as well as an agent with activity against MRSA. Definitive antibiotic treatment should be tailored according to blood and or tissue gram stain, culture, and sensitivity results when available.[@ref27] If *S. marcescens* is identified as the main pathogen, third-generation cephalosporins, fluoroquinolones, and imipenem/cilastatin are the antimicrobials of choice. Our patient's fever on presentation was likely masked by the pain medications she was taking, though she did give a history of having fever at home. She most likely had a subacute course and thus lacked the classic features of rapid clinical progression and fulminant toxicity. An HIV test was not performed, as the patient did not have any risk factors or any previous sexually transmitted disease. Our review noted a mortality rate of 53% among those with *S. marcescens*-induced necrotizing fasciitis, which is higher than the mortality rate reported by Elliott *et al*.[@ref28] in 1996 and nearly equivalent (53% *vs*. 50%) to the mortality rate documented by Nancy *et al.* in 2002.[@ref29] Patients who died were more likely to have positive blood cultures, present with a community-acquired illness, be previously healthy, experience minor trauma or sickness prior to symptom onset, and not receive both surgical debridement and antibiotic therapy. Similar observations of increased mortality among those with positive blood cultures or those not receiving appropriate antibiotic and surgical treatment were also found in other studies.^[@ref4],[@ref26]^ Increased mortality among individuals with less severe injury, lack of traditional risk factors, and those who did not have a recent surgical procedure in the hospital may have been due to less vigilance about changes in health status and the fact that *S. marcescens* is common in the outdoor environment; these individuals were also more likely to have community-acquired infections (70% *vs*. 30%). Additionally, individuals who had been hospitalized recently were more likely to have received antibiotics in the near past and also more likely to be wary of any new symptoms. Healthy patients also tend to seek care later and receive less aggressive treatment; only one of the previously healthy patients received both antibiotics and surgical debridement.

Clinicians should be wary of necrotizing fasciitis among those with soft tissue infections presenting after environmental open skin exposure. Gram-negative bacilli, including *S. marcescens*, should especially be considered in cases of necrotizing fasciitis or cellulitis among immunocompromized persons with renal failure, steroid use, recent surgery or diabetes.[@ref29] Early diagnosis is key, but unfortunately is missed in 85 to 100% of cases since necrotizing fasciitis is often confused with cellulitis, myositis, or deep-seated abscess(es). A high index of suspicion is important in view of the paucity of specific cutaneous findings early in the course of the disease. Radiographic imaging studies may be useful in determining if muscle tissue is involved but should not delay surgical intervention. Our case also underscores the importance of preoperative and more so, postoperative wound care education, which could have potentially prevented this fatal complication.[@ref30] The most effective treatment regimen for suspected necrotizing fasciitis includes: early and aggressive surgical exploration and debridement, immediate broad spectrum empiric antibiotic therapy, and hemodynamic support as necessary.^[@ref4],[@ref26]^

We thank our case patient, the hospital, and other doctors involved in the care of this case patient.
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*Serratia marcescens* necrotizing fasciitis cases, 1966 to present.

  Author                           Year   Age   Sex   Risk factors                           Precipitating factor                                                  Site of infection                         Type    *S. marcescens* cultures   Treatment            Outcome
  -------------------------------- ------ ----- ----- -------------------------------------- --------------------------------------------------------------------- ----------------------------------------- ------- -------------------------- -------------------- -----------
  Rimailho *et al.*[@ref10]        1987   74    M     Immunocompromized                      Dilofenac consumption                                                 Leg                                       CA      Blister and blood          None                 Died
  Bornstein *et al.*[@ref11]       1992   37    F     Renal failure on hemodialysis          Pain during dialysis                                                  Axilla and chest wall                     HA      Wound, bullae, blood       Antibiotics and SD   Recovered
  Zipper *et al.*[@ref12]          1996   55    F     Diabetes                               Left below-knee amputation                                            Leg                                       CA      Wound                      Antibiotics          Recovered
  Huang *et al.*[@ref13]           1999   73    M     Nephrotic syndrome                     Steroid therapy                                                       Lower leg                                 HA      Necrotic tissue, blood     Antibiotics and SD   Recovered
  Huang *et al.*[@ref13]           1999   40    M     Uremia, peritoneal dialysis, SLE       Pneumonia with + cultures for S. marcescens, steroid and nabumetone   Left calf and thigh                       CA      Necrotic tissue, blood     Antibiotics and SD   Recovered
  Liangpunsakul *et al.*[@ref14]   2001   66    F     Healthy                                None                                                                  Leg                                       CA      Blood                      Antibiotics          Died
  Newton *et al.*[@ref15]          2002   2     F     Healthy                                Pharyngitis                                                           Cervical spine                            CA      Wound, blood               Antibiotics and SD   Died
  Bachmeyer *et al.*[@ref16]       2004   49    M     Small cell lung cancer, DM             Chemotherapy and cellulitis                                           Right leg                                 HA      Tissue, bullae, blood      Antibiotics          Recovered
  Curtis *et al.*[@ref4]           2005   51    M     ESRD, T2DM, CHF                        Scraped knee on rock in river                                         Left leg                                  CA      Wound, blood               Antibiotics and SD   Died
  Statham *et al.*[@ref17]         2009   6     M     Immunocompetent                        Suspected pharyngitis                                                 Oro-pharynx                               CA      Wound, blood               Antibiotics and SD   Recovered
  Motsitsi *et al.*[@ref18]        2011   37    M     Healthy                                Human bite                                                            Forearm                                   CA      Wound                      SD                   Died
  Vano-Galvan *et al.*[@ref7]      2012   57    F C   ML, immunocompromize                   d Minor trauma                                                        Right thigh                               HA      Blister, blood             Antibiotics          Died
  Prelog *et al.*[@ref19]          2012   15    F     Acute lymphocyctic leukemia            Venous access port implantation                                       Left axilla, venous HA access port site   Wound   Antibiotics and SD         Recovered            
  Wen *et al.*[@ref20]             2012   40    F     Nephrotic syndrome, cyclosporine use   Chemotherapy 10 daysprior                                             Left leg                                  CA      Wound, blood               Antibiotics          Died
  Rehman *et al.*[@ref21]          2012   54    F     SLE, end-stage renal disease           Central venous catheter, AV fistula ligation, steroid therapy         Chest wall                                HA      Wound, blood               Antibiotics and SD   Died
  Present case                            51    F     DM, PVD                                Bifemoral bypass and left distal femoral aneurysm repair              Lower abdomen                             CA      Wound, blood               Antibiotics and SD   Recovered
  Cope *et al.*[@ref22]            2013   97    F     Heat failure, CKD                      Heart failure exacerbation                                            Right leg                                 HA      Wound (post-mortem)        Antibiotics          Died

SD, Surgical debridement; CA, community-acquired infection; HA, healthcare-associated infection; SLE, systemic lupus erythematosus; ESRD, end-stage renal disease; T2DM, Type II, diabetes mellitus; PVD, peripheral vascular disease.
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